2023
DOI: 10.1016/j.xops.2022.100261
|View full text |Cite
|
Sign up to set email alerts
|

Macular Telangiectasia Type 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…An EZ loss was observed in all cases at the time of SRNV onset. Before their progression to SRNVs, one or more ORNV tracts with ORHR with (four eyes) or without (four eyes) pigment (stages 4 and 5 of the recent MacTel classification 19 ) were observed (Figures 2 and 3). In these eight eyes, the mean VA decreased from 20/40 to 20/50.…”
Section: Resultsmentioning
confidence: 99%
“…An EZ loss was observed in all cases at the time of SRNV onset. Before their progression to SRNVs, one or more ORNV tracts with ORHR with (four eyes) or without (four eyes) pigment (stages 4 and 5 of the recent MacTel classification 19 ) were observed (Figures 2 and 3). In these eight eyes, the mean VA decreased from 20/40 to 20/50.…”
Section: Resultsmentioning
confidence: 99%
“…In advanced stages, hyperplasia of the retinal pigment epithelium and subretinal neovascularization can result in vision impairment . Although the current standard for MacTel diagnosis relies on multimodal imaging (fundus photography, fluorescein angiography, fundus autofluorescence, and optical coherence tomography [OCT] imaging), a variety of findings are apparent on OCT imaging at all stages of disease …”
Section: Introductionmentioning
confidence: 99%